Active Ingredient History

  • Now
Pregabalin, marketed under the brand name Lyrica among others. LYRICA is indicated for: Neuropathic pain associated with diabetic peripheral neuropathy (DPN) Postherpetic neuralgia (PHN); Adjunctive therapy for adult patients with partial onset seizures; Fibromyalgia; Neuropathic pain associated with spinal cord injury. It has been shown the clinical effects of pregabalin are likely due to direct and selective interactions with α(2)δ-1 and α(2)δ-2 subunits of voltage-gated calcium channels. While pregabalin is a structural derivative of the inhibitory neurotransmitter gamma aminobutyric acid (GABA), it does not bind directly to GABAA, GABAB, or benzodiazepine receptors, does not augment GABAA responses in cultured neurons, does not alter rat brain GABA concentration or have acute effects on GABA uptake or degradation. However, in cultured neurons prolonged application of pregabalin increases the density of GABA transporter protein and increases the rate of functional GABA transport. Pregabalin does not block sodium channels, is not active at opiate receptors, and does not alter cyclooxygenase enzyme activity. It is inactive at serotonin and dopamine receptors and does not inhibit dopamine, serotonin, or noradrenaline reuptake.   NCATS

  • Mol. Mass: 159.2261
  • ALogP: 1.08
  • ChEMBL Molecule:
More Chemistry

Drug Pricing (per unit)

United States

$0.0231 - $14.1162


$0.0809 - $0.4091
More Pricing Detail

Note: This drug pricing data is preliminary, incomplete, and may contain errors.

3-isobutyl gaba | alzain | axalid | ci-1008 | gabanext | kw21052 | lecaent | lyrica | maxgalin | pd-144723 | pregabalin | pregabalin hcl | pregabalin hydrochloride | pregaballine | rewisca | (s)-3-isobutyl gaba | s-(+)-3-isobutylgaba | (s)-pregabalin


Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue